Tham khảo Satraplatin

  1. ↑ Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab (2010). “The status of platinum anticancer drugs in the clinic and in clinical trials”. Dalton Transactions. 39 (35): 8113–8127. doi:10.1039/C0DT00292E. PMID 20593091.
  2. ↑ Kelland, Lloyd R.; Abel, George; McKeage, Mark J.; Jones, Mervyn; Goddard, Phillis M.; Valenti, Melanie; Murrer, Barry A.; Harrap, Kenneth R. (1993). “Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug” (PDF). Cancer Res. 53 (11): 2581–2586. PMID 8388318.
  3. 1 2 3 4 Choy, Hak; Park, Clinton; Yao, Min (2008). “Current status and future prospects for satraplatin, an oral platinum analogue”. Clin. Cancer Res. 14 (6): 1633–1638. doi:10.1158/1078-0432.CCR-07-2176. PMID 18347164.
  4. ↑ Satraplatin — Spectrum Pharmaceuticals Error in Webarchive template: Empty url.
  5. 1 2 3 4 5 Bhargava, Ashish; Vaishampayan, Ulka N. (2009). “Satraplatin: Leading the new generation of oral platinum agents”. Expert Opin. Investig. Drugs. 18 (11): 1787–1797. doi:10.1517/13543780903362437. PMC 3856359. PMID 19888874.